Original Article | Iran J Pathol.2018; 13(3):325-332 Iranian Journal of Pathology | ISSN: 2345-3656 Association of Helicobacter pylori Infection With Colon Cancer and Adenomatous Polyps Fatemeh Teimoorian1, Mohammad Ranaei2*, Karimollah Hajian Tilaki3, Javad Shokri Shirvani 4, Zeinab Vosough1 1. 2. 3. 4. Dept of Pathology, School of Medicine, Babol University of Medical Sciences, Babol, Iran Clinical Research Development Center, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran Dept of Statistic and Epidmiology, School of Medicine, Babol University of Medical Sciences, Babol, Iran Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran KEYWORDS Neoplasias, Adenomatous Polyps, Helicobacter pylori Infection, Serum, Immunoglobulins Article Info Received 23 Feb 2017; Accepted 18 Aug 2018; Published Online 12 Sep 2018; ABSTRACT Background and objective: Helicobacter pylori infection is one of the most common chronic bacterial infections in the world, especially in the developing countries. This bacterium is the cause of many diseases such as lymphoma, gastritis, peptic ulcers, and stomach cancer. According to recent reports, H. pylori infection can potentially increase the risk of colon cancer. The current study aimed at investigating the association of H. pylori infection and the risk of colorectal cancer and adenomatous polyps. Methods: The current study was conducted on 50 patients with colon cancer and adenomatous polyps as the case group and 100 subjects with no specific pathologies (i e, polyps, neoplasms, or inflammatory diseases) as the control group. Blood samples were collected from the patients in order to assess the presence of anti-Helicobacter pylori infection antibodies, and the serum titer levels of anti-Helicobacter pylori IgG and IgA antibodies were measured using indirect enzyme-linked immunosorbent assay (ELISA) and a kit procured by Pishtaz Teb Company (Iran). Results: A total of 33 patients in the current study had adenomatous polyps and 17 had colon cancer. H. pylori infection (IgA >20 U/mL and IgG >10 U/mL) was significantly more prevalent in the patients with colon cancer and adenomatous polyps compared with the healthy controls (P= 0.003, P= 0.039, respectively). Conclusion: The obtained results suggested that H. pylori infection can be considered as a risk factor for colon cancer and adenomatous polyps. Corresponding information: Dr. Mohammad Ranaei, Clinical Research Development Center, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran E-mail: [email protected] Copyright © 2018, IRANIAN JOURNAL OF PATHOLOGY. This is an open-access article distributed under the terms of the Creative Commons Attribution-noncommercial 4.0 International License which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited. Introduction Colorectal cancer (CC) is the 3rd leading cancer in the world and its prevalence is rising in the developing countries (1). Colorectal cancer is a heterogeneous tumor involving a population of different cells with distinct properties (2). This cancer develops following the growth of cancer cells in the colon, rectum, and the appendix (3). Both environmental and genetic factors affect the incidence of this cancer (4). According to the Iranian Cancer Association, around one million people in Iran develop colorectal cancer every year. The incidence of this type of cancer increased in Iran over the past 25 years (5) and is currently the 3rd leading type of cancer in females and the 5th in males Vol.13 No.3 Summer 2018 in the country (6). The diagnosis of colorectal cancer in early stages prevents its progress and prolongs the survival of the patients. Many studies show that chronic infection with gastric Helicobacter pylori, which is a risk factor for stomach cancer (7), may also be associated with a moderately increased risk of colorectal cancer (8-11). Most colorectal cancers originate from adenomatous polyps. Adenomas are premalignant lesions that partly turn into cancer (12). Many studies show that H. pylori infection is associated with an increased serum gastrin. Endocrinological studies show that hypergastrinemia is associated with rectal cell proliferation and stimulates the growth of colorectal cancer IRANIAN JOURNAL OF PATHOLOGY Mohammad Ranaei et al.326 cells and the development of colon adenoma and the adenoma-cancer sequence. These results suggest that H. pylori infection can potentially increase the risk of colorectal cancer (13). Materials and methods The current case-control study was conducted on 50 patients diagnosed with colon cancer and all types of adenomatous polyps visiting Ayatollah Rouhani Hospital in Babol from 21st March 2015 to 20th march 2016 as the case group and 100 patients undergoing colonoscopy without pathologic findings (including polyps, neoplasms, inflammatory diseases, etc.) as the control group. Any patient in the case and control groups with inflammatory bowel disease (IBD), nonadenomatous polyps, and history of cancer or eradication therapy of H. pylori infection prior to colonoscopy was excluded from the study. Both groups were selected with consecutive sampling method. After obtaining written consent from the patients, the two groups were matched in terms of age, gender, family history of colorectal cancer, clinical symptoms (rectorrhagia, stomach ache, change in bowel habits, vomiting, weight loss, diarrhea, and iron deficiency anemia). There are several H. pylori diagnostic tests including invasive tests (endoscopy, biopsy, histopathology, rapid urease, and polymerase chain reaction (PCR) and non-invasive tests (respiratory urease, the enzyme-linked immunosorbent assay (ELISA), and stool antigen); the current study employed the ELISA method due to its high sensitivity, specificity, and simplicity (14). To investigate the presence of antiHelicobacter pylori antibodies, 1 mL venous blood sample was collected from each subject and sent to laboratories and the serum was isolated and used to measure serum titer levels of anti-Helicobacter pylori IgG and IgA using indirect ELISA and the kit procured by Pishtaz Teb Co. (Iran) (IgA >20 U/mL manufacturer’s cut off point for IgA positivity and IgG >10 U/mL manufacturer’s cut off point for IgG positivity) and according to the instructions provided by the kit manufacturer (15). Data were analyzed with SPSS version 20 using Chi-square and t test at the significance level of <0.05. Results A total of 150 patients took part in the study, including 50 patients diagnosed with colon cancer and adenomatous polyp as the cases and 100 subjects with no reports of tumors or polyps in their colonoscopy or pathology results as the controls. The mean age of the subjects was 51 years; 88 (58.6%) were male and 62 (41.4%) female. None of the subjects had a history of IBD. Table 1 presents the subjects’ demographic details. No significant differences were observed in the prevalence of adenomatous polyps and colon cancer between the genders. No significant differences were observed between the subjects with a history of gastrointestinal cancer in themselves or their families and the ones with no such history in terms of the prevalence of adenomatous polyps and colon cancer. Nonetheless, a significant difference was observed between the subjects aged 50 and below and the ones aged over 50 in the prevalence of adenomatous polyps and colon cancer (P=0.048). Table 1. Demographics, Personal and Family History of Colon Neoplasm in the Studied Groups Normal N (%) Polyp N (%) Cancer N (%) Male 55 (55) 22 (66.7) 11 (64.7) Female 45 (45) 11 (33.3) 6 (35.3) 50≤ 51 (51) 24 (72.7) 12 (70.6) >50 49 (49) 9 (27.3) 5 (29.4) Negative 96 (96) 31 (93.9) 16 (94.1) Positive 4 (4) 2 (6.1) 1 (5.9) Negative 95 (95) 28 (84.8) 17 (100) Positive 5 (5) 5 (15.2) - Characteristic Gender Age Cancer history Family history Vol.13 No.3 Summer 2018 P-value 0.431 0.048 0.860 0.065 IRANIAN JOURNAL OF PATHOLOGY 327.Association of Helicobacter pylori Infection With... A total of 33 patients had adenomatous polyps and 17 had colon cancer. Of the 33 cases of polyps, 16 were located in the right and 17 in the left colon. Of the 17 cases of colon cancer, eight were found in the right and nine in the left colon. No significant differences were observed in terms of the location of adenomatous polyps and cancer (P=0.58). According to Table 2, H. pylori infection with IgA >20 U/mL (manufacturer’s cut off point for IgA positivity) was significantly higher in the patients with colon cancer and adenomatous polyps compared with the healthy controls (P=0.003). H. pylori infection with IgG>10 U/mL (manufacturer’s cut off point for IgG positivity) was also significantly higher in the patients with colon cancer and adenomatous polyps compared with the healthy controls (P=0.039). According to Table 3, H. pylori infection with IgA >20 U/mL was significantly higher in the male patients with colon cancer and adenomatous polyps compared with the healthy controls (P=0.001), but no significant differences were observed between the female patients with colon cancer and adenomatous polyps compared with the healthy controls (P=0.054). H. pylori infection with IgG >10 U/mL was significantly higher in the male patients with colon cancer and adenomatous polyps compared with the healthy controls (P=0.012), but no significant differences were observed between the female patients with colon cancer and adenomatous polyps compared with the healthy controls (P=0.247). Results showed that H. pylori infection with IgA>20 U/mL was significantly higher in the patients with colon cancer and adenomatous polyps aged 50 or below compared with the healthy controls (P=0.009). In different age groups, H. pylori infection with IgG >10 U/mL did not differ significantly between the patients with colon cancer and adenomatous polyps and the healthy controls (P=0.262). Table 2. IgA and IgG Serum Levels in the Study Groups Serum Level, U/mL Normal N (%) Polyp N (%) Cancer N (%) Total N (%) * IgA>15 82 (82) 21 (63.6) 7 (41.2) 110 (73.3) 15 ≤ IgA <20 IgA≤20 IgG** <5 7 (7) 11 (11) 54(54) 4 (12.1) 8 (24.2) 14 (42.4) 2 (11.8) 8 (47.1) 3 (17.6) 13 (8.7) 27 (18) 110 (47.3) 5≤ IgG < 10 14 (14) 5 (15.2) 2 (11.8) 13 (14) IgG≤10 32 (32) 14 (42.4) 12 (70.6) 27 (38.7) P-value 0.003 0.039 *immunoglobulin A **immunoglobulin G Table 3. IgA and IgG Serum Levels in the Study Groups Based on Gender Serum level U/mL Male Female Male Female Normal N (%) Polyp N (%) Cancer N (%) Total N (%) IgA <15 43(78.2) 16 (72.7) 2 (18.2) 61 (69.3) 15≤ IgA <20 6 (10.9) 3 (13.6) 2 (18.2) 11 (12.5) 20≤ IgA 6 (10.9) 3 (13.6) 7 (63.6) 16 (18.2) IgA <15 39 (86.7) 5 (45.5) 5 (83.3) 49 (79) 15≤ IgA <20 1 (2.2) 1 (9.1) - 2 (3.2) 20≤ IgA 5 (11.1) 5 (45.5) 1 (16.7) 11 (17.7) IgG <5 32 (58.2) 9 (40.9) 2 (18.2) 43 (48.9) 5≤ IgG <10 6 (10.9) 5 (22.7) - 11 (12.5) 10 ≤ IgG 17 (30.9) 8 (36.4) 9 (81.8) 34 (38.6) IgG <5 22 (48.9) 5 (45.5) 1 (16.7) 28 (45.2) 5≤IgG <10 8 (17.8) 0 (0) 2 (33.3) 10 (16.1) 10 ≤IgG 15 (33.3) 6 (54.5) 3 (50) 24 (38.7) Vol.13 No.3 Summer 2018 P-value 0.001 0.054 0.012 0.247 IRANIAN JOURNAL OF PATHOLOGY Mohammad Ranaei et al.328 Discussion A total of 33 patients had adenomatous polyps, 16 of which were located in the right and 17 in the left colon, and 17 others had colon cancer, eight of which were in the right and nine in the left colon. H. pylori infection (either current or past H. pylori colonization identified by IgA >20 U/mL and IgG >10 U/ mL as instructed by manufacturer and used by same studies) (15) was significantly higher in the patients with colon cancer and adenomatous polyps compared with the healthy controls (P=0.003 and P=0.039, respectively). H. pylori are the microorganism repeatedly observed throughout the world. Although most infected people are asymptomatic, the infection becomes chronic when affecting humans. H. pylori can infect humans for the whole life (16-18). This organism is rarely eradicated spontaneously with any treatments, and post-therapy recurrence is also reported, especially in countries with a high prevalence of H. pylori infection (19). The mechanism by which H. pylori increases the risk of colorectal cancer is not yet clearly understood. Inflammation and the loss of cell cycle are among the mechanisms suggested to be involved. CagA has a pathogenic role in H. pylori, and the presence of CagA in H. pylori is associated with an increased risk of stomach cancer (20, 21). Infection with H. pylori causes the secretion of serum gastrin, which can act as a growth hormone for the colonic mucosa cells (22 ,23). H. pylori can cause hypergastrinemia alone or together with changes in the normal gastrointestinal flora, suggesting an acceptable mechanism for the carcinogenicity of this organism. In a recent study conducted by Robertson, increased serum gastrin following polypectomy was not associated with an increased risk of adenomatous polyp recurrence (24). A number of observational studies examined the correlation between positive serum H. pylori and the risk of colorectal cancer (9, 25-27). Nonetheless, their results were inconclusive. Two studies reported a positive correlation (24, 25) and four others found no relationships at all between this infection and the cancer (9, 26-28). In a case-control study conducted Vol.13 No.3 Summer 2018 by Penman et al., (29) on hospitalized patients to assess gastrin levels and the risk of colorectal neoplasia, serum levels of H. pylori were similar in the patients with colorectal cancer and the healthy controls. The two groups were also similar in terms of age and gender. In a meta-analysis conducted in 2013 by Chen et al., on the relationship between H. pylori infection and the risk of colorectal adenoma and adenocarcinoma, it was observed that H. pylori infection increased the risk of colorectal adenoma and adenocarcinoma. In a study conducted by Fireman et al. (13), the prevalence of H. pylori antibodies was significantly higher in the group of patients with colorectal cancer than the healthy controls; however, the difference was only borderline significant (P=0.05). In the current study, H. pylori infection was significantly higher in the patients with colon cancer and adenomatous polyps compared with the healthy controls. In contrast, in a case-control study conducted by Talley (31) the serum levels of H. pylori were clearly higher in the patients with cancer compared with the healthy controls, although not significantly. Two other studies with relatively small sample sizes (n=41 and n=38) found no acceptable differences in serum levels of H. pylori between the group of patients with colorectal cancer and the healthy controls (32, 33). In two studies that used PCR to detect H. pylori, the prevalence of H. pylori was significantly higher in colorectal adenocarcinoma tissue compared with the healthy colorectal tissue examined (34, 35). In three studies, however, H. pylori species was detected in only 1.2% of the malignant adenocarcinoma tissue and 6% of the normal colorectal tissue (36). In another study, Fujimari et al., (9) reported H. pylori infection as a risk factor for colorectal adenoma and cancer, especially in females; in females, H. pylori infection increases the risk of colorectal adenoma and cancer at ages 40 to 80 years; the cited study detected H. pylori using respiratory urease test. In the study conducted by Liou et al. (37), no relationships were observed between H. pylori infection (detected using respiratory urease test) and colorectal adenoma. The current study, however, found a significant relaIRANIAN JOURNAL OF PATHOLOGY 329.Association of Helicobacter pylori Infection With... tionship between H. pylori infection and colon cancer and adenomatous polyps with the application of IgA and IgG H. pylori antibodies. In the current study, the prevalence of colon cancer and adenomatous polyps did not differ significantly in the right and left colons. In the study by Brim et al. (38), no relationships were observed between H. pylori infection and the risk of colorectal polyps, while a significant relationship was observed between these two variables in the current study. This disparity of findings may be attributed to the lower prevalence of H. pylori infection in the region studied by Brim et al. Brim et al., (39) showed a significant increase in the incidence of colorectal polyps in the older-than-40 African-American population. In the current study, the prevalence of colon cancer and adenomatous polyps was significantly higher in subjects aged over 50 years compared with the ones aged 50 and below. In a study conducted by Buso et al. (39), females with H. pylori infection had a higher risk of developing colorectal tumor. Fujimori et al., (9) and Jones et al., (34) showed a higher odds ratio (OR) of developing colorectal adenocarcinoma in females infected with H. pylori compared with males with such infection; however, the relationship was not significant. The higher risk of colon adenoma in females is associated with hormonal factors. The mean age of the participants was over 50 years in the current study, which was indicative of reduced serum of sex hormone levels. Estrogen and progesterone reduce the risk of colon adenoma and adenocarcinoma. The association of H. pylori infection and reduced sex hormones in females increases the risk of colon neoplasia. Nonetheless, the current study found a significant relationship between H. pylori infection and colon cancer and adenomatous polyps in males but not in females. The disparity of findings between this and other studies may be due to the lower mean age in the females that participated in the current study. In another study, Zhang et al., (40) studied H. pylori infection and revealed an increased risk of left colon cancer with an OR of 1.22 and therefore suggested that H. pylori infection may be somewhat associated with an increased risk of left colon cancer. Buso et al., (39) and Inoue et al., (25) showed that the risk of late-stage adenoma increased significantly in the presence of H. pylori infection. Fujimori et al., (9) and Abbass et al., (41) found no relationships between H. pylori infection and the location of colorectal neoplasia. Brim et al., (38) also observed no relationships between H. pylori infection and the location of colorectal polyps. Vol.13 No.3 Summer 2018 The main limitation of the current study was the absence of a gold standard method to diagnose H. pylori infection such as endoscopic biopsy, urea breath test, and stool antigen test since the sensitivity and specificity of serological method is less than such tests. Conclusion The obtained results suggested that H. pylori infection can be considered a risk factor for colon cancer and adenomatous polyps. Further prospective studies with larger sample sizes are required to accurately assess the role of H. pylori infection in such pathologies. The eradication of this infection and its reassessment in patients after eradication can help to determine the role of this organism in different pathologies. The clinical significance of these findings also cannot be safely interpreted since the pathophysiology of this phenomenon is still unclear and further basic studies should be conducted in this field. Acknowledgment Authors wish to thank the Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, for assistance to discuss the case and edit the article. Conflict of interest The authors declare that there was no conflict of interest. IRANIAN JOURNAL OF PATHOLOGY Mohammad Ranaei et al.330 Reference 1. ma, especially in women. J Gastroenterol 2005 ; 40 : 887 – 93. https://doi.org/10.1007/s00535- Ferlay J, Shin HR, Bray F, Forman D, Mathers 005-1649-1 C, Parkin DM. Estimates of worldwide burden of cancer in 2008. Int J Cancer 2010; 127(12): 2893-2917. 2. 10. PMid:21351269 Helibacter pylori infection, interlukin-1 gen Gutman M, Fidler IJ. Biology of human colon polymorphisms and the risk of colorectal cancer: evidence from a case-control study in Germany. Eur J Cancer. 2007 May; 43(8): 1283- 226-234. https://doi.org/10.1007/BF00308631 9. PMid:7754628 11. ser326Cys, XPC Lys939Gln and XPD Lys751 1979; 43(5): 1847-1857. PMID: 445371 Gln polymorphisms in a Turkish population Monajemmi AR. Cancer. Second ed. Tehran: with colorectal carcinoma. Genet Test Mol Azadmhr Publication; 2000. Biomarkers.2010; 14(4): 559-64. https://doi. Azadeh S, Moghimi-Dehkordi B, Fatem SR, org/10.1089/gtmb.2009.0195 PMid:20649433 Pourhoseingholi MA, Ghiasi S, Zali MR. Colorectal cancer in Iran: an epidemiological 12. moidoscopy screening in prevention of Atkin 123-126. PMid:18439090 colorectal cancer: A multicenter randomisde Kolahdoozan S, Sadjadi A, Radmard AR, Kha- controlled trial. The Lacent journal. 2010; demi H. Five common cancers in Iran. Arch Iran 375(9726): 1624-33. Med . 2010; 13(2): 143-146. PMid:20187669 7. Limburg PJ, Stolzenberg-Solomon RZ, Colbert 13. lence and colorectal cancer. Isr Med Assoc J. and colorectal cancer risk: a prospective study 2000; 2(1):6 –9. PMid:10892362 of male smokers.Cancer Epidemiol Biomarkers 8. 14. IgA and IgM serologic testing compared to Zuchowicz M, Labza H, Konturek PC and et al. stool antigen testing. Clin Vaccin Immunol. Helicobacterpylori infection, gastrin, cyclooxy- 2009; 16(8): 1253-5. https://doi.org/10.1128/ genase-2 and apoptosis in colorectal cancer. Int J CVI.00149-09 colorectal Dis. 2001; 16(4): 202-10. https://doi. 9. Fujimori S , Kishida T , Kobayashi Tet al.Helicobacter pylori infection increases the risk of colorectal adenoma and adenocarcinoVol.13 No.3 Summer 2018 She RC, Wilson AR, Litwin CM. Evaluation of helicobacterpylori immunoglobulin G(IgG), Hartwich A, Konturek SJ, Pierzchalski P, org/10.1007/s003840100288 PMid:11515678 Fireman Z, Trost L, Kopelman Y, Segal A, and Sternberg A. Helicobacter pylori: seropreva- LH and et al . Helicobacter pylori seropositivity Prev. 2002; 11: 1095-9. PMid:12376513 Edwards R, Kralj-Hans I, Wooldrige K, Hart A, Northover J, et al. Once only flexible sig- study. Asian Pacific J Cancer Prev. 2008; 9(1): 6. Engin AB, Karahail B, Engin A, Karakaye AE. Oxidative stress, helicobacterpylori and OGG1 of the large bowel: an autopsy survey. Cancer 5. https://doi.org/10.1016/j.ejca.2007.03.005 PMid:17446060 Rickert RR, Auerbach O, Garfinkel L, Hammond EC, Frasca JM. Adenomatous lesions 4. Zumkeller N, Brenner H, Chang-Claud J, Hoffmeister M, Nieters A, Routhenbacher D. https://doi.org/10.1002/ijc.25516 cancer metastasis. World J Surg 1995; 19(2): 3. PMid:16211345 15. PMid:19515865 Owrang M, Tahmasbpour Marzony E, Imami S, Darzi H, Nejadmoghadam A. Comparison of IgG and IgA antibodies titration against helicobacterpylori in urban and rural population in IRANIAN JOURNAL OF PATHOLOGY 331.Association of Helicobacter pylori Infection With... 16. Mazandaran province. Journal of Fasa univer- with increased risk of distal colon adenomas sity of medical sciences. 2014; 4(1): 50-7. . Digestion 2006; 74 : 42 – 6 . https://doi. Graham DY, Malaty HM, Evans DG, Evans DJ org/10.1159/000096593 Jr, Klein PD, Adam E. Epidemiology of Heli- 17. trin, Helicobacter pylori, andcolorectal adeno- in the united state: gastroentology: 1991; 100: mas . Clin Gastroenterol Hepatol 2009; 7: 163– 1495-1501. PMID: 2019355 7 . https://doi.org/10.1016/j.cgh.2008.09.006 Fontham ET, Ruiz B, Perez A, Hunter F, Correa PMid:18929688 25. Elevated risk of colorectal adenoma withHeli- Gastroenterology. 1995;90(7). cobacter pylori-related chronic gastritis: a pop- Lauren P. The two histological main types of ulationbased case control study. Int J Cancer. gastric carcinoma: diffuse and so‐called intesti- 2011 ; 129 : 2704 – 11 . https://doi.org/10.1002/ nal‐type carcinoma: an attempt at a histo‐clini- ijc.25931 PMid:21225622 26. logica Scandinavica. 1965;64(1):31-49. colorectal cancer risk: a case-control study . Hildebrand P, Bardhan P, Rossi L, Parvin S, Reinfection with helicobacter pylori after eradi- 2007 ; 12 : 328 – 32 . PMID: 17669106 27. pylori infection is associatedwith colon ad- enterology, 2001; 121: 792-798. https://doi. enomatous polyps detected by high-resolu- org/10.1053/gast.2001.28018 PMid:11606492 tion colonoscopy. Int J Cancer. 2005 ; 117 : Beales IL, Crabtree JE, Scunes D, et 1058– al.Antibodies to CagA protein are associated- PMid:15986436 28. 9. https://doi.org/10.1002/ijc.21280 Siddheshwar RK, Muhammad KB, Gray JC fection. Eur J Gastroenterol Hepatol. 1996; 8: and et al. Seroprevalence of Helicobacter py- 645-9. lori in patients with colorectal polyps and PMid:8853252 colorectal carcinoma. Am J Gastroenterol 2001; Maeda S, Mentis AF. Pathogenesis of He- 21. licobacter pylori infection. 96: 84 – 8 . https://doi.org/10.1111/j.1572- Helicobacter. 0241.2001.03355.x 2007; 12: 10-4. https://doi.org/10.1111/j.15235378.2007.00529.x 23. Mizuno S, Morita Y, Inui Tet al. Helicobacter cation therapy in bangladeshi adults. Gastro- with gastric atrophy in Helicobacter pylori in- 22. Machida-Montani A, Sasazuki S, Inoue M et al. Atrophic gastritis,Helicobacter pylori, and Rahman A, Arefin MS,et al., Recurence and 20. Inoue I , Mukoubayashi C , Yoshimura Net al. tion and chronic gastritis. American Journal of cal classification. Acta Pathologica Microbio- 19. Robertson DJ, Sandler RS, Ahnen DJ et al. Gas- cobacter pylori in an asymptomatic population P. Determinants of Helicobacter pylori infec- 18. 24. PMid:17068397 PMid:17727454 29. PMid:11197293 Penman ID, El-Omar E, Ardill JE, McGregor Thorburn CM, Friedman GD, Dickinson CJet JR, Galloway DJ, O’Dwyer PJ, and McColl al. Gastrin and colorectal cancer: a prospective KE. Plasma gastrin concentrations are nor- study . Gastroenterology . 1998; 115 : 275 – 80 . mal in patients with colorectal neoplasia and https://doi.org/10.1016/S0016-5085(98)70193- unaltered following tumor resection. Gastro- 3 enterology. 1994; 106: 1263–70. https://doi. org/10.1016/0016-5085(94)90018-3 Georgopoulos SD, Polymeros D, Triantafyllou K, et al. Hypergastrinemia is associated Vol.13 No.3 Summer 2018 30. Chen Y.S, Xu S.X, Ding Y.B, Huang X.E, IRANIAN JOURNAL OF PATHOLOGY Mohammad Ranaei et al.332 Deng B. Helicobacter pylori Infection and the quencing analysis. J Med Microbiol. 2005; 54: Risk of Colorectal Adenoma and Adenocarci- 1031-5. https://doi.org/10.1099/jmm.0.46122-0 noma: an Updated Meta analysis of Different 31. 33. Helicobacter pylori in colorectal carcinomatis- 14(12): 7613-19. https://doi.org/10.7314/AP- sue. Cancer Epidemiol Biomarkers Prev. 2007; JCP.2013.14.12.7613 16: 631-3. https://doi.org/10.1158/1055-9965. PMid:24460342 Talley NJ, Zinsmeister AR, Weaver A, DiM37. Liou JM, Lin JW, Huang SP and et al. Helicobacter pylori infection is not associatedwith in- cobacter pylori infection. J Natl Cancer Inst. creased risk of colorectal polyps in Taiwanese. 1991;83: 1734 –39. https://doi.org/10.1093/ Int J Cancer. 2006; 119: 1999-2000. https://doi. jnci/83.23.1734 org/10.1002/ijc.22050 PMid:16708392 PMid:1770552 Moss SF, Neugut A, Garbowski GC, Wang S, 38. Brim H, Zahrf M, Laiyemo A and et al. Gastric Treat MR and Forde KA. Helicobacter pylori Helicobacter pylori infection associates with seroprevalence and colorectal neoplasia: evi- an increased risk of colorectal polyps in Afri- dence against an association. J. Natl. Cancer can Americans. BMC Cancer 2014, 14:296- Inst. 1995; 87: 762–65. https://doi.org/10.1093/ 303. https://doi.org/10.1186/1471-2407-14-296 jnci/87.10.762 PMid:24774100 PMCid:PMC4022546 Meucci G, Tatarella M, Vecchi M, Ranzi ML, 39. Buso AG, Rocha HL, Diogo DM, Diogo PM, Biguzzi E, Beccari G, Clerici E and de Fran- Diogo-Filho A. Seroprevalence of Helicobacter chis R. High prevalence of Helicobacter pylori pylori in patients with colon adenomas in a infection in patients with colonic adenomas Brazilian university hospital. Arq Gastroen- and carcinomas. J. Clin Gastroenterol. 1997; terol.2009; 46: 97-101. https://doi.org/10.1590/ 25: 605–7. https://doi.org/10.1097/00004836- S0004-28032009000200004 40. PMid:19578608 Zhang Y, Hoffmeister M, Melanie N. Weck and Jones M, Helliwell P, Pritchard C and et al. et al. Helicobacter pylori infection and colorec- Helicobacter pylori in colorectalneoplasms: tal cancer risk: evidence from a large popula- is there an aetiological relationship? World tion-based case-control study in Germany. Am J Surg Oncol. 2007; 5: 51-5. https://doi. J Epidemiol. 2012; 175: 441-50. https://doi. org/10.1186/1477-7819-5-51 org/10.1093/aje/kwr331 PMid:22294430 PMid:17498313 PMCid:PMC1885433 35. EPI-06-1031 PMid:17372266 Blaser MJ. Gastric adenocarcinoma and Heli- 199712000-00011 34. Bulajic M, Stimec B, Jesenofsky R and et al. Testing Methods. Asian Pac J Cancer Prev. agno EP, Carpenter HA, Perez-Perez GI, and 32. 36. 41. Abbass K, Gul W, Beck G, Markert R, Akram Grahn N, Hmani-Aifa M, Fransen K and et al. S. Association of Helicobacter pylori infection Molecular identification of HelicobacterDNA with the development of colorectal polyps and present in human colorectal adenocarcinomas colorectal carcinoma. South Med J. 2011; 104: by 16s rDNAPCR amplifiation and pyrose- 473-6. PMid:21886044 How to Cite This Article Teimoorian F, Ranaei M, Hajian-Tilaki K, Shokri Shirvani J, Vosough Z. Association of Helicobacter pylori infection and colon cancer and adenomatous polyps. Iranian Journal of Pathology, 2018; 13(3): 325-332 Vol.13 No.3 Summer 2018 IRANIAN JOURNAL OF PATHOLOGY
